Arcutis Biotherapeutics, Inc. (ARQT) total liabilities

Total liabilities · fiscal 2025
$243.49M

Arcutis Biotherapeutics, Inc. (ARQT) had total liabilities of $243.49M at the end of fiscal 2025 (December 31, 2025). That is 27.3% higher than the $191.35M of fiscal 2024. Figures as of 19 Nov 2026, 13:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$243.49M
Change on fiscal 2024
+27.3%
Growth, 5 years
+54.5% a year
Highest on record
$252.70Mfiscal 2023
Lowest on record
$5.55Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Arcutis Biotherapeutics, Inc. total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 54.5% a year. Across the 7 fiscal years on record (2019–2025), the highest was $252.70M in fiscal 2023 and the lowest $5.55M in fiscal 2019.

History · 7 fiscal years

Total liabilities by fiscal year

Arcutis Biotherapeutics, Inc. total liabilities, year by year

Arcutis Biotherapeutics, Inc. (ARQT) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$243.49M 27.3% up
2024$191.35M 24.3% down
2023$252.70M 5.4% up
2022$239.69M 117.0% up
2021$110.48M 299.6% up
2020$27.65M 398.2% up
2019$5.55M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

More on ARQT

Arcutis Biotherapeutics, Inc., figure by figure

Arcutis Biotherapeutics, Inc. (ARQT) overview: price, valuation and scorecard

Arcutis Biotherapeutics, Inc. total liabilities: questions and answers

How large are Arcutis Biotherapeutics, Inc.'s total liabilities?

Arcutis Biotherapeutics, Inc. (ARQT) had total liabilities of $243.49M at the end of fiscal 2025 (December 31, 2025). That is 27.3% higher than the $191.35M of fiscal 2024.

What is the growth rate of Arcutis Biotherapeutics, Inc.'s total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 54.5% a year.

What are the highest and lowest total liabilities figures on record for Arcutis Biotherapeutics, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was $252.70M in fiscal 2023 and the lowest $5.55M in fiscal 2019.

How is Arcutis Biotherapeutics, Inc.'s total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Arcutis Biotherapeutics, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Arcutis Biotherapeutics, Inc. (ARQT) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/ARQT/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.